Author: Matthew Scholz

If Seattle is to occupy a future place of dominance in the biotech world, it must foster more of an “incubator” culture. There is a “valley of death” between the well-funded labs of academia and private venture funding that is difficult to cross. The National Institutes of Health funds non-profit institutions like universities for fundamental … Continue reading “Seattle Needs an “Incubator” Culture”